Industry Experts

Assieh Saadatpour is Director of Biomarker Analytics for Interventional Oncology at Johnson & Johnson. She leads efforts leveraging multi-omics data and AI-driven analytics to advance cancer drug discovery and development. She also drives initiatives to implement Generative AI use cases to enhance efficiency across the portfolio. Previously, she worked on computational immuno-oncology at Merck and single-cell genomics at Dana-Farber Cancer Institute and Harvard School of Public Health. Assieh holds a Ph.D. in Mathematics and a Ph.D. minor in Computational Science from Penn State. She is passionate about using data, AI, and partnerships to accelerate precision oncology.